CompletedNot Applicable

Lung Ultrasound in PD Patients

Turkey (Türkiye)23 participantsStarted 2018-05-01

Plain-language summary

Although many alternative methods are present, maintaining ideal volume status in peritoneal dialysis (PD) patients still rely on clinical evaluation due to lack of an evidence based method. Lung ultrasound (LUS) is a new method for evaluation of hidden congestion in this group. LUS findings and its relationship with other volumetric methods are investigated in this study. LUS was performed to all peritoneal dialysis patients and compared with symptoms of hypervolemia, physical examination, vascular endothelial growth factor-C (VEGF-C) and N-terminal pro-brain natriuretic peptide levels, chest radiography, echocardiography, bioelectrical impedance analysis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients older than 18 years old, * History of PD more than 3 months, * Providing written informed consent Exclusion Criteria: * Patients younger than 18 years old, * Unwilling to participate to the study, * Immobile patients unable to perform test in the same day, * History of PD less than 3 months, * Presence of active infection, * History of lung cancer and/or operations.

What they're measuring

Association Between Number of Kerley B Lines by Ultrasound and Serum VEGF-C Level (pg/ml) by Enzyme-linked Immunosorbent Assay

Timeframe: 4 months

Trial details

NCT IDNCT03801044

SponsorSisli Hamidiye Etfal Training and Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-09-01

Results submitted2019-02-07

View on ClinicalTrials.gov More Peritoneal Dialysis trials